Published in

Wiley, Macromolecular Rapid Communications, 1(35), p. 27-43, 2013

DOI: 10.1002/marc.201300792

Links

Tools

Export citation

Search in Google Scholar

“Bio”-Macromolecules: Polymer-Protein Conjugates as Emerging Scaffolds for Therapeutics

Journal article published in 2013 by Dorothee E. Borchmann, Tom P. Carberry, Marcus Weck ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Polymer-protein conjugates are biohybrid macromolecules derived from covalently connecting synthetic polymers with polypeptides. The resulting materials combine the properties of both worlds: chemists can engineer polymers to stabilize proteins, to add functionality, or to enhance activity; whereas biochemists can exploit the specificity and complexity that Nature has bestowed upon its macromolecules. This has led to a wealth of applications, particularly within the realm of biomedicine. Polymer-protein conjugation has expanded to include scaffolds for drug delivery, tissue engineering, and microbial inhibitors. This feature article reflects upon recent developments in the field and discusses the applications of these hybrids from a biomaterials standpoint.